As CD8+PD1+ T cells failed to execute effective immune surveillance, but rather showed tissue-damaging potential, we reasoned that CD8+ T cells might be involved in promoting NASH–HCC. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.